infertility treatment

Phase 2

• Conditions: Infertility.; In vitro fertilization

• Registration Number: IRCT201105316665N1
• Lead Sponsor: Vice Chancellor for Research, Hamadan University of Medical Science,

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

having a morphologically normal uterus; infertility from tubal; male, endometriosis or unexplained factors; infertility over than 5 years. Excluding criteria: existing the known systemic diseases in both groups

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Beta hCG. Timepoint: two weeks. Method of measurement: radioimmunoassay.

Secondary Outcome Measures

Name	Time	Method
Embryo implantation. Timepoint: immediately after beta hCG positivity (two weeks after than intervention). Method of measurement: ultrasonography.